Related Experiment Video
Updated: Aug 1, 2026
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
Immunohistochemistry (IHC) staining of in-vitro cancer cell-generated tumoroids
Meitham Amereh1, Mohsen Akbari1
1Laboratory for Innovations in MicroEngineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, BC V8W 2Y2, Canada.
Abstract:
Targeting different pathways in combinational therapy may lead to synergistic effects with higher drug efficiency. Due to a large number of candidate drugs and the variability in the genomic landscape of the disease, conventional cell culture models have limited success. Three-dimensional (3D) cell culture platforms such as tumoroids not only provide a pathophysiological relevant condition but also allow for low-cost and high-throughput drug screening strategies. Immunostaining of targeted proteins within a tumoroid is challenging as the interior cells are difficult to access via a non-destructive method. Immunohistochemistry (IHC) is an important technique in clinical research to explore the expression of various biomarkers. IHC staining of tumoroids allows non-destructive detection of unstable proteins by direct fixation of cells at the state of tumor microenvironment (TME) context, providing two main advantages. First, the target protein can be fixed without dissociating cells and disintegration of tumoroids into a single-cell suspension. Second, staining the preserved structure of tumoroids helps identify the location of the target proteins as well as the spatial distribution throughout the tumoroid geometry. In this protocol, we describe the detailed methodology of a non-destructive IHC staining of cancer biomarkers which minimizes the manipulation of tumoroids prior to fixation by eliminating multiple centrifugations and shaking steps typically required for removing excess hydrogel and collecting tumoroids. The protocol can be used in studies involving prognostic and predictive biomarker investigations in new anti-tumor drug development strategies.
Insights
This study presents a novel, non-destructive immunohistochemistry (IHC) protocol for cancer tumoroids. This method enhances drug screening by preserving tumor microenvironment context and protein localization for biomarker investigation.
Area of Science:
- Biomedical Engineering
- Cancer Biology
- Drug Development
Background:
- Three-dimensional (3D) cell cultures, like tumoroids, offer a more relevant model for cancer research than traditional cell cultures.
- Investigating combinational therapy requires efficient drug screening, which is hindered by the complexity of cancer genomics and limitations of current cell models.
- Immunostaining within tumoroids is difficult due to accessibility issues for interior cells, limiting biomarker analysis.
Purpose of the Study:
- To develop a non-destructive immunohistochemistry (IHC) protocol for analyzing cancer biomarkers in tumoroids.
- To enable accurate assessment of protein expression and spatial distribution within the tumor microenvironment (TME).
- To facilitate high-throughput drug screening and biomarker investigation for new anti-cancer therapies.
Main Methods:
- A novel protocol for non-destructive IHC staining of cancer biomarkers in tumoroids was developed.
- The method minimizes manipulation of tumoroids before fixation, avoiding cell dissociation and hydrogel removal steps.
- Direct fixation preserves the tumoroid structure and intracellular proteins within their native TME context.
Main Results:
- The protocol allows for non-destructive detection of unstable proteins by direct fixation.
- Preserved tumoroid structures enable precise localization and spatial distribution analysis of target proteins.
- The method eliminates centrifugation and shaking steps, simplifying tumoroid processing.
Conclusions:
- This non-destructive IHC protocol significantly improves biomarker analysis in tumoroids.
- It supports prognostic and predictive biomarker investigations in anti-tumor drug development.
- The technique enhances the utility of tumoroids for low-cost, high-throughput drug screening strategies.
More Related Videos
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
04:21Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry
Published on: January 26, 2024
